My gut feeling is that we could be close to an an interested party collaborating on an MOU (Memorandum of Understanding).
I'm sure that the MND trial is being closely monitored by Big Pharma. The final biomarker data and analysis will be the inflection point for an MOU to be enacted. With further funding for Phase 2 by Fight MND and the potential of Orphan Drug Designation by FDA will make MPL a highly attractive prospect to an interested party.
https://www.investopedia.com/terms/m/mou.asp
It could be a couple of weeks before the MND data is completed so my bet is on early October for a significant announcement.
All my opinion only.
Cheers, Thrifty
Ann: Additional Phase 1 data suggest MPL may inhibit MND, page-259
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.030(12.8%) |
Mkt cap ! $81.16M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 20.5¢ | $276.8K | 1.274M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 134649 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 65000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
21.0¢ |
Change
-0.030 ( 8.70 %) |
||||
| Open | High | Low | Volume | ||
| 22.5¢ | 23.0¢ | 21.0¢ | 615701 | ||
| Last updated 15.56pm 06/06/2024 ? | |||||
| PAA (ASX) Chart |